malignant phosphaturic mesenchymal tumor of bone相关文献:
Genetic profiling of a chondroblastoma-like osteosarcoma/malignant phosphaturic mesenchymal tumor of bone reveals a homozygous deletion of CDKN2A, intragenic deletion of DMD, and a targetable FN1-FGFR1 gene fusion.
PMID:
Clinical Characteristics of Malignant Phosphaturic Mesenchymal Tumor Causing Tumor-Induced Osteomalacia.
Abate V, Vergatti A, De Filippo G, Damiano V, Menale C, D'Elia L, Rendina D.
J Clin Endocrinol Metab. 2024 Feb 20;109(3):e1006-e1011. doi: 10.1210/clinem/dgad690.
PMID:38006315
Phosphaturic Mesenchymal Tumor.
Benson JC, Trejo-Lopez JA, Nassiri AM, Eschbacher K, Link MJ, Driscoll CL, Tiegs RD, Sfeir J, DeLone DR.
AJNR Am J Neuroradiol. 2022 Jun;43(6):817-822. doi: 10.3174/ajnr.A7513. Epub 2022 May 19.
PMID:35589138
Tumor-induced Osteomalacia: A Comprehensive Review.
Minisola S, Fukumoto S, Xia W, Corsi A, Colangelo L, Scillitani A, Pepe J, Cipriani C, Thakker RV.
Endocr Rev. 2023 Mar 4;44(2):323-353. doi: 10.1210/endrev/bnac026.
PMID:36327295
Tumor-Induced Osteomalacia.
Florenzano P, Hartley IR, Jimenez M, Roszko K, Gafni RI, Collins MT.